Post-marketing surveillance for refractory uveoretinitis associated with Behcet's disease under Remicade treatment
Not Applicable
- Conditions
- Behcet's disease
- Registration Number
- JPRN-UMIN000027733
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who meet "CONTRAINDICATIONS" to the use of Remicade
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method